<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="19" ids="27560,33609,51707">Boron</z:chebi> neutron capture therapy (BNCT) was proposed for untreatable colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The present study evaluates <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> control and potential radiotoxicity of BNCT in an experimental model of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>BDIX rats were inoculated with syngeneic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DHD</z:e>/K12/TRb </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>-bearing animals were divided into three groups: BPA-BNCT, boronophenylalanine (BPA) + neutron irradiation; Beam only, neutron irradiation; Sham, matched manipulation </plain></SENT>
<SENT sid="4" pm="."><plain>The total absorbed dose administered with BPA-BNCT was 13 ± 3 Gy in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and 9 ± 2 Gy in healthy liver </plain></SENT>
<SENT sid="5" pm="."><plain>Three weeks post-treatment, the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> surface area post-treatment/pre-treatment ratio was 0.46 ± 0.20 for BPA-BNCT, 2.7 ± 1.8 for Beam only and 4.5 ± 3.1 for Sham </plain></SENT>
<SENT sid="6" pm="."><plain>The pre-treatment <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> nodule mass of 48 ± 19 mg fell significantly to 19 ± 16 mg for BPA-BNCT, but rose significantly to 140 ± 106 mg for Beam only and to 346 ± 302 mg for Sham </plain></SENT>
<SENT sid="7" pm="."><plain>For both end points, the differences between the BPA-BNCT group and each of the other groups were statistically significant (ANOVA) </plain></SENT>
<SENT sid="8" pm="."><plain>No clinical, macroscopic or histological <z:mpath ids='MPATH_458'>normal</z:mpath> liver radiotoxicity was observed </plain></SENT>
<SENT sid="9" pm="."><plain>It is concluded that BPA-BNCT induced a significant remission of experimental <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> nodules in liver with no contributory liver toxicity </plain></SENT>
</text></document>